214 related articles for article (PubMed ID: 30018377)
1. Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.
Kishazi E; Dor M; Eperon S; Oberic A; Turck N; Hamedani M
Sci Rep; 2018 Jul; 8(1):10792. PubMed ID: 30018377
[TBL] [Abstract][Full Text] [Related]
2. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Huang D; Luo Q; Yang H; Mao Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4935-43. PubMed ID: 24994866
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.
Huang D; Xu N; Song Y; Wang P; Yang H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):619-25. PubMed ID: 22124787
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-associated orbitopathy and tears: A proteomics study.
Kishazi E; Dor M; Eperon S; Oberic A; Hamedani M; Turck N
J Proteomics; 2018 Jan; 170():110-116. PubMed ID: 28887209
[TBL] [Abstract][Full Text] [Related]
5. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines.
Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV
Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
7. The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.
Mandić JJ; Kozmar A; Kusačić-Kuna S; Jazbec A; Mandić K; Mrazovac D; Vukojević N
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):845-852. PubMed ID: 29332250
[TBL] [Abstract][Full Text] [Related]
8. Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids.
Xu N; Cui Y; Fu D; Sun F
J Endocrinol Invest; 2020 Jul; 43(7):901-910. PubMed ID: 31927748
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the levels of interleukin-17 and interleukin-38 in thyroid-associated ophthalmopathy patients.
Mussakulova A; Balmukhanova A; Aubakirova A; Zhunusova G; Balmukhanova A; Issakhanova J; Saliev T; Tanabayeva S; Fakhradiyev I
Int Ophthalmol; 2023 Aug; 43(8):2811-2824. PubMed ID: 36894821
[TBL] [Abstract][Full Text] [Related]
10. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
11. Tears as a Source of Biomarkers in the Diagnosis of Graves' Orbitopathy.
Bajkowska D; Szelachowska M; Buczyńska A; Krętowski AJ; Siewko K
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358969
[TBL] [Abstract][Full Text] [Related]
12. Proteomics Differentiate Between Thyroid-Associated Orbitopathy and Dry Eye Syndrome.
Matheis N; Grus FH; Breitenfeld M; Knych I; Funke S; Pitz S; Ponto KA; Pfeiffer N; Kahaly GJ
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2649-56. PubMed ID: 25829418
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of tear fluid in thyroid-associated orbitopathy.
Matheis N; Okrojek R; Grus FH; Kahaly GJ
Thyroid; 2012 Oct; 22(10):1039-45. PubMed ID: 22873942
[TBL] [Abstract][Full Text] [Related]
14. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
15. Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves' Ophthalmopathy.
Song RH; Wang B; Yao QM; Li Q; Jia X; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2020; 20(1):87-95. PubMed ID: 31237218
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score.
Choi W; Li Y; Ji YS; Yoon KC
BMC Ophthalmol; 2018 Nov; 18(1):303. PubMed ID: 30463536
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
18. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
19. The Change of Lacrimal Gland Volume in Korean Patients with Thyroid-associated Ophthalmopathy.
Huh HD; Kim JH; Kim SJ; Yoo JM; Seo SW
Korean J Ophthalmol; 2016 Oct; 30(5):319-325. PubMed ID: 27729751
[TBL] [Abstract][Full Text] [Related]
20.
Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S;
Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
